Skip to content

Clinical trials

Completed Glomerulonephritis, IGA trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Status: Completed Country / region: South Korea Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20111
20131
20141
20183
20191
20202
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Calliditas Therapeutics AB2
Alexion Pharmaceuticals, Inc.1
Anthera Pharmaceuticals1
Arrowhead Pharmaceuticals1
Astellas Pharma Inc1
HI-Bio, A Biogen Company1
Kuhnil Pharmaceutical Co., Ltd.1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Seoul National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA16
Kidney Diseases4
Proteinuria4
Renal Insufficiency, Chronic3
Glomerulonephritis2
Urologic Diseases2
Autoimmune Diseases1
Diabetic Nephropathies1
Glomerulonephritis, Membranoproliferative1
Glomerulosclerosis, Focal Segmental1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.